Demetrix, Inc. Overview
Pro stress-test →Demetrix is a biotechnology company specializing in developing innovative solutions for the production of cannabinoids and other complex natural products through fermentation technology. Using microorganisms such as baker's yeast and fermentation combined with advanced biotechnology, data science and automation, Demetrix produces complex, sustainable ingredients at high purity and lower cost.
Strategic Profile
Pro stress-test →Founded in 2015 and headquartered in Emeryville, the company focuses on biotechnology applications in cannabinoid production. The global market for cannabinoids is expected to reach $100 billion by 2029. Demetrix addresses supply chain limitations by replacing traditional plant cultivation with fermentation-based production of high-purity cannabinoids.
Competitive Landscape
Pro stress-test →Demetrix competes in the synthetic biology and biofermentation space for natural products and cannabinoids. Direct competitors include Ginkgo Bioworks (broader synthetic biology platform), Impossible Foods (food-focused fermentation), and traditional cannabis cultivators/extractors. Demetrix differentiates through fermentation-based production of rare cannabinoids at high purity and lower cost than plant extraction.
Industry Context
Demetrix, Inc. operates in Synthetic biology and biofermentation for natural products.
Key facts
Founded: 2015 · Headquarters: Emeryville, CA · Employees: 21 · Revenue: $3.8M · Market cap: N/A